Luoxin Pharmaceuticals Group Stock Co Ltd (002793) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.059x

Based on the latest financial reports, Luoxin Pharmaceuticals Group Stock Co Ltd (002793) has a cash flow conversion efficiency ratio of 0.059x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥90.75 Million ≈ $13.28 Million USD) by net assets (CN¥1.53 Billion ≈ $223.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Luoxin Pharmaceuticals Group Stock Co Lt's balance sheet to measure how much of total assets are equity-financed.

Luoxin Pharmaceuticals Group Stock Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Luoxin Pharmaceuticals Group Stock Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 002793 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Luoxin Pharmaceuticals Group Stock Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Luoxin Pharmaceuticals Group Stock Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
KPI Green Energy Limited NSE:KPIGREEN	0.007x
Apotea ST:APOTEA	0.120x
Shenzhen INVT Electric Co Ltd SHE:002334	0.060x
PROSEGUR CASH UNSP.ADR/5 F:PQD0	N/A
China Railway Signal & Communication Corporation Limited F:RS3	0.008x
Wushang Group Co Ltd SHE:000501	0.033x
Hunan Jiudian Pharmaceutical Co Ltd SHE:300705	0.068x
Kerjaya Prospek Group Bhd KLSE:7161	0.003x

Annual Cash Flow Conversion Efficiency for Luoxin Pharmaceuticals Group Stock Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Luoxin Pharmaceuticals Group Stock Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Luoxin Pharmaceuticals Group Stock Co Lt.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.24 Billion ≈ $180.82 Million	CN¥253.07 Million ≈ $37.03 Million	0.205x	+289.35%
2024-12-31	CN¥1.46 Billion ≈ $213.56 Million	CN¥-157.85 Million ≈ $-23.10 Million	-0.108x	-150.33%
2023-12-31	CN¥2.57 Billion ≈ $376.42 Million	CN¥552.79 Million ≈ $80.89 Million	0.215x	+175.66%
2022-12-31	CN¥3.31 Billion ≈ $483.84 Million	CN¥-939.13 Million ≈ $-137.42 Million	-0.284x	-1215.03%
2021-12-31	CN¥4.74 Billion ≈ $692.99 Million	CN¥120.63 Million ≈ $17.65 Million	0.025x	+442.04%
2020-12-31	CN¥4.35 Billion ≈ $636.59 Million	CN¥-32.40 Million ≈ $-4.74 Million	-0.007x	-125.36%
2019-12-31	CN¥3.96 Billion ≈ $579.73 Million	CN¥116.33 Million ≈ $17.02 Million	0.029x	-76.59%
2018-12-31	CN¥909.89 Million ≈ $133.14 Million	CN¥114.12 Million ≈ $16.70 Million	0.125x	-7.52%
2017-12-31	CN¥754.19 Million ≈ $110.36 Million	CN¥102.27 Million ≈ $14.97 Million	0.136x	+30.19%
2016-12-31	CN¥698.33 Million ≈ $102.19 Million	CN¥72.74 Million ≈ $10.64 Million	0.104x	-39.16%
2015-12-31	CN¥339.50 Million ≈ $49.68 Million	CN¥58.12 Million ≈ $8.51 Million	0.171x	+29.11%
2014-12-31	CN¥315.46 Million ≈ $46.16 Million	CN¥41.83 Million ≈ $6.12 Million	0.133x	-48.50%
2013-12-31	CN¥251.50 Million ≈ $36.80 Million	CN¥64.75 Million ≈ $9.48 Million	0.257x	+58.84%
2012-12-31	CN¥205.54 Million ≈ $30.08 Million	CN¥33.31 Million ≈ $4.88 Million	0.162x	-47.10%
2011-12-31	CN¥151.87 Million ≈ $22.22 Million	CN¥46.53 Million ≈ $6.81 Million	0.306x	--

About Luoxin Pharmaceuticals Group Stock Co Ltd

SHE:002793 China Drug Manufacturers - Specialty & Generic

Market Cap

$814.84 Million

CN¥5.57 Billion CNY

Market Cap Rank

#9757 Global

#2492 in China

Share Price

CN¥5.12

Change (1 day)

+10.11%

52-Week Range

CN¥3.80 - CN¥5.95

All Time High

CN¥25.07